HAL (France)open access
Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery
Nivolumab, Melanoma, Plain language summary, Recurrence-free survival, Adjuvant, Relatlimab, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1079658
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.